 Armata Pharmaceuticals NYSEAMERICAN:ARMPs stock had its buy rating restated by analysts at LADENBURG THALMSH SH in a research note issued on Monday, AnalystRatings.com reports. They currently have a 9.00 price target on the stock. LADENBURG THALMSH SHs target price suggests a potential upside of 136.22 from the stocks previous close. Several other equities analysts have ... 